On June 11th, Hunan Taosun Medical Equipment Co., Ltd (hereinafter referred to as “Taosun Medical”) announced the completion of tens of millions of A round of financing. This round of financing is exclusively invested by Jinchu Weitai Capital, which will further accelerate the research and development of new projects and the strategic layout of the product market.

In Taosun Medical's newly completed base building, Ms. Lu Ye, Managing Partner of Jinchu Weitai Capital, and Dr. Xiao Jiayi, President of Tao Shang Medical, signed the strategic investment agreement on behalf of both parties, opening a new chapter of cooperation.

     The proceeds from the financing will be used for the scale production and market promotion of mobile CT and mobile CT medical carts with independent intellectual property rights, accelerating the construction of China's first regional medical operation center by counties, and boosting the popularization and application of China's mobile medical care and the collaborative development of primary medical care.

    Taosun Medical was founded in 2018, settled in Ningxiang, Hunan Province in 2021, and reached a strategic cooperation with “China Mobile-Ministry of Education Joint Laboratory of Mobile Healthcare”. Taosun Medical has a research team focusing on medical imaging technology, and has accumulated rich technology on the research path of mobile CT, mobile MRI and digital X-ray detector, etc. Currently, the company has developed 4 CT models, 2 mobile CT medical carts, and a mobile low-field MRI.

    So far, the company has obtained 6 invention patents and more than 30 patents of various types. The company has been awarded the title of Hunan Province Specialized, Specialized and New Small and Medium-sized Enterprises, National High-tech Enterprises, etc., and has won a number of awards in the provincial and municipal innovation and entrepreneurship related events. We believe that under the support of Jinchu Weitai, Taosun Medical can quickly layout the market and achieve excellent market answer.